Cellular Origin of Melanoma Tracked Down

As melanoma develops, the cells that are eventually reprogrammed, lose their differentiated features and become invasive, migratory cancer cells.

Melanoma occurs when the pigment-producing cells that give colour to the skin become cancerous. Symptoms might include a new, unusual growth or a change in an existing mole. Led by Jean-Christophe Marine (VIB-KU Leuven), a team of researchers has tracked down the cellular origin of cutaneous melanoma, the deadliest form of skin cancer.

The team was surprised to observe that these very aggressive tumors arise from mature, pigment-producing cells called melanocytes. As melanoma develops, these cells are eventually reprogrammed, lose their differentiated features and become invasive, migratory cancer cells. This knowledge is vital to understand how these melanoma lesions are formed, facilitate their early detection and develop preventive treatment avenues. The results of the study are published in the academic journal Cell Stem Cell.

SerpinE2: Essential Target to Fight Melanoma Metastasis
Understanding the biological events that take place at distant sites from the primary tumor is crucial for preventing or slowing metastasis.

‘The identification of the cancer cell of origin has important clinical implications, as it enables doctors to detect malignancies earlier and predict tumor behavior more accurately.’

Although cutaneous melanoma is common and often fatal, the precise cellular origin of this malignant cancer has been under debate for quite some time. Prof. Marine and his team generated a refined mouse model that faithfully reproduces the early stages of melanoma development in humans. The researchers used single-cell tracking and profiling approaches and live imaging techniques to identify the earliest cellular origin of melanoma and monitor the changes that these cells experience as they first become malignant and then transform into invasive cancer cells.

Pigmented melanocytes identified as cancerous culprits

Mature melanocytes, which produce pigments in the upper layer of the skin, contribute to melanoma formation. These highly specialized cells, which normally do not divide, did divide when exposed to a specific melanoma-causing mutation. The researchers observed them covering the entire topmost layer of the skin and forming benign lesions before changing their appearance. The cells progressively lost the characteristics that make them melanocytes. At that point, they began invading deeper skin layers as migratory and invasive cancer cells.

Three Strains Of Gut Bacteria Improve Treatment Response in Melanoma
Certain good bacteria in the gut can optimize the effectiveness of checkpoint inhibitors that fight cancer cells.

Prof. Jean-Christophe Marine (VIB-KU Leuven): "Unexpectedly, this ability to divide and contribute to melanoma development contrasted with the activities of other cell populations, such as melanocyte stem cells found in hair follicles, for instance. Because these other skin cell types showed no signs of expansion or transformation, our analysis highlights pigment-producing cells as the originators of melanoma."

Microenvironmental cues play a role

Combination Therapy Doubles Relapse-Free Survival in Stage III Melanoma
The combination of dabrafenib and trametinib improved overall survival and was well tolerated, in patients with advanced, BRAF-mutant melanoma.

The study suggested that microenvironmental cues dictate the cell of origin of melanoma. Factors secreted by the locations containing non-pigmented melanocytes, such as melanocyte stem cells, appear to be able to suppress early cancer development. Identifying these factors will require additional studies, which may ultimately lead to the identification of novel anti-melanoma therapeutics.

Prof. Jean-Christophe Marine (VIB-KU Leuven): "Importantly, our work also provides clear evidence that non-dividing, differentiated cells with highly specialized functions can be genetically reprogrammed later in life to become cancer-causing cells."

Link Between Melanoma Pathway & Novel Therapeutic Agent Found
Wnt signaling pathway and autophagy are associated, whereby Wnt plays a major role in the response to autophagy inhibitors and can aid in melonoma therapy.

Buying valuable time for patients

There is clear evidence that thin, early-stage melanomas have better prognoses, since surgical removal at this stage is extremely effective. The identification of the cancer cell of origin has important clinical implications, as it enables doctors to detect malignancies earlier and predict tumor behavior more accurately.

Source-Eurekalert